HISTORY OF PRESENT ILLNESS:  This is a 71-year old female with known diabetes, congestive heart failure, atrial fibrillation, peripheral [**Year (4 digits) 1106**] disease who presents for pre-hydration for an arteriogram of her right lower extremity.
She has a right lower extremity ulcer which occurred after removal of ankle hardware last month.
PAST MEDICAL HISTORY:  Includes type 2 diabetes (insulin dependent), congestive heart failure (with an ejection fraction of 50% to 55%), history of chronic atrial fibrillation (anticoagulated), coronary artery disease, status post angioplasty in [**2109**], [**2110**] and [**2113**], history of pulmonary hypertension, history of hyperlipidemia, history of COPD (with home O2), history of pulmonary embolus, history of obstructive sleep apnea (on CPAP), history of depression/anxiety, history of aortic endocarditis (treated), history of chronic anemia.
PAST SURGICAL HISTORY:  Includes thyroidectomy, laparoscopic cholecystectomy, a right thoracotomy decortication, and a right hip and ankle open reduction/internal fixation.
MEDICATIONS ON ADMISSION:  Include Lasix 40 mg/80 mg daily, lisinopril 5 mg daily, Celexa 60 mg daily, Synthroid 200 mcg daily, multivitamin tablet, Zocor 20 mg daily, aspirin 325 mg daily, Coumadin, Lopressor 25 mg t.i.d., Atrovent 2 puffs b.i.d., Fentanyl patch, oxycodone, Dilantin, Toprol XL 50 b.i.d., Protonix 40 daily, OxyContin 10 mg daily, Neurontin 600 mg b.i.d.
(Monday and Wednesday), Lantus insulin 18 units daily.
IV hydration was begun in anticipation for an arteriogram with a creatinine of 1.5.
On [**9-23**], the patient underwent abdominal aortogram with bilateral runoff and a right above-the-knee amputation.
She required a unit of packed red blood cells intraoperatively.
She required Neo-Synephrine at 0.3 units/kg/min for systolic blood pressure support.
She was weaned off her Neo- Synephrine.
On postoperative day 2, the patient required Haldol for night confusion with an improvement.
She continued on the Neo-Synephrine and diltiazem drips.
Vancomycin, levofloxacin, and Flagyl were continued.
A regular insulin sliding scale was begun.
Her central line was discontinued.
On postoperative day 5, physical therapy was requested to see the patient in anticipation for discharge planning.
Antibiotics were discontinued on [**2123-9-28**].
Her beta blockade was reinstituted.
The skin clips should remain in place until seen in followup.
The patient's INR's should be monitored; and her goal INR should be 2.0 to 3.0 and Coumadin dose adjusted accordingly.
DISCHARGE MEDICATIONS:  Lisinopril 5 mg daily, levothyroxine 200 mcg daily, citalopram hydrobromide 60 mg daily, simvastatin 20 mg daily, methylphenidate 10 mg q.a.m.
and 5 mg at lunch, aspirin 325 mg daily, fluticasone actuation aerosol 110 mcg 2 puffs b.i.d., Fentanyl patch 75 mcg per hour q.72h., miconazole nitrate powder to affected area, Lasix 80 mg daily, albuterol/ipratropium bromide 103/18 mcg actuation aerosol 1 to 2 puffs q.6h., topiramate 15 mg b.i.d., Protonix 40 mg daily, oxycodone 10 mg sustained release q.12h., gabapentin 600 mg b.i.d.
and 900 mg at [**Year (4 digits) 21013**], insulin glargine 18 units at [**Year (4 digits) 21013**], diltiazem 30 mg q.i.d., Nystatin swish-and-swallow q.i.d., lorazepam 0.5 mg q.8h.
p.r.n., oxycodone 5 to 10 mg q.4h.
(for breakthrough pain), metoprolol tartrate 25 mg t.i.d., Coumadin 2.5 mg daily at [**Year (4 digits) 21013**].
Status post angioplasty to coronary arteries in [**2109**], [**2110**]    and [**2113**].
